Register Now
Youtube Linkedin Facebook
DXPX and AACC Logos in white

Sponsors & Partners

Again, this year our conference is supported by global players and industry leaders.

Long-term partnerships

Knowledge partners of the DxPx conferences represent leading companies and organizations providing services to early to mid-stage life science companies, investors, and major healthcare corporations.

We are proud that these partners support our vision for DxPx and provide continuous, long-term support and strategy advice.

Knowledge partnerships are exclusive for each industry vertical such as IP / law services, fundraising & M&A advisors, strategy consulting, recruiting and accounting services.

“Great organization and execution”

Brown Gibbons Lang & Company LLC
christoph brandenberger

Christoph D. Brandenberger

Managing Director

“Proud to support DxPx since 2018 and seeing the development!”

McDermott Will & Emery LLP
Angus McQuilken

Angus McQuilken

Industry Relationship Executive

Download information on the DxPx Sponsoring Packages

After you have filled out the form, the PDF download will start automatically.

    First name

    Last name

    E-mail

    Sponsors

    Diamond Sponsor

    Brown Gibbons Lang & Company LLC

    Gold Sponsor

    Gold Sponsor

    AdvaMed

    Gold Sponsor

    McDermott Will & Emery LLP

    Gold Sponsor

    thermofisher

    Silver Sponsor

    dxpx_conference_sponsor_logo_500_150_DMC_EDA

    Silver Sponsor

    dxpx_conference_sponsor_logo_500_150_General_Inception

    Silver Sponsor

    sponsor_dxpx_42plus1_eu_2022_dusseldorf_HSE

    Bronze Sponsor

    dxpx_conference_sponsor_logo_500_150_elastrin

    Bronze Sponsor

    dxpx_conference_sponsor_logo_500_150_mybiogate_xinxin

    Bronze Sponsor

    dxpx_conference_sponsor_logo_500_150_PL_Bioscience

    Bronze Sponsor

    qiagen logo sponsordxpx eu conference

    Featured Media Partners:

    dxpx_conference_sponsor_logo_500_150_360DX
    dxpx_conference_sponsor_logo_500_150 oost nl
    Pharmatech_outlook_magazine_media_partner_dxpx_us_2023_logos_500x150_and_12rad
    Brown Gibbons Lang & Company LLC

    Investment banking

    Healthcare & Life Sciences

    Brown Gibbons Lang & Company (BGL) is a leading independent investment bank and financial advisory firm focused on the global middle market. We advise private and public corporations and debt and equity sponsors on mergers and acquisitions, capital markets, financial restructurings, valuations and opinions, real estate, and other strategic matters.
    christoph brandenberger
    Christoph D. Brandenberger, Managing Director
    John Riddle
    John Riddle, Managing Director
    McDermott Will & Emery LLP

    Life sciences

    Strategic Solutions

    As a life sciences company, your intellectual property is your most valuable asset—it’s what propels your growth, drives your success and sets you apart from competitors. But it may also be your most vulnerable asset. How you commercialize your innovation and gain compliance is crucial for the success of your business.
    Angus McQuilken
    Angus McQuilken, Industry Relationship Executive
    SilverSky LifeSciences GmbH

    Life sciences

    Fund raising and M&A support

    We believe that it takes an entrepreneur to advise an entrepreneur. We therefore aim to ensure that our consultants either come with personal operational management experience or gain know-how through the development of our portfolio companies. With a team able to rely on over 100 years of operational experience in the management of diagnostics.

    Curious how joining one of the DxPx conferences in Europe or US as partner or sponsor can help your business?

    Contact us
    A brief introduction to DxPx

    Don't miss our investor conferences & early-stage investing events:

    dxpx us adlm logos
    DxPx US

    DxPx Industry & Investor Conference US:
    4 Days In-Person

    July 29 - Aug. 1, 2024
    Chicago, IL
    In the ADLM

    Stay up to date and sign up for our latest news:

    Next: DxPx U.S. 2025
    • 3 Days In-Person
    • July 29 - 31, 2025
    • McCormick Place
      Convention Center
      Chicago, Illinois, USA
    Next: DxPx EU 2026
    • 2 Days In-Person
    • Reception: February 5, 2026
      Partnering Day & 42PLUS1:
      February 6, 2026
    • Munich, Germany
    Download Brochure
    DxPx media
    Useful links

    © Copyright DxPx 2025. All Rights Reserved.

    Youtube Linkedin Facebook

    Oliver Dick

    Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

    Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

    Experience

    Christoph Brandenberger

    Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

    A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

    Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

    Experience

    John Riddle

    John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

    John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

    Experience

    Dr. Mirko Stange

    Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

    In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

    Experience

    FName LName

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

    Experience